These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 15795937)

  • 1. Enhanced angiogenesis characteristic of SPARC-null mice disappears with age.
    Reed MJ; Bradshaw AD; Shaw M; Sadoun E; Han N; Ferara N; Funk S; Puolakkainen P; Sage EH
    J Cell Physiol; 2005 Sep; 204(3):800-7. PubMed ID: 15795937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPARC-thrombospondin-2-double-null mice exhibit enhanced cutaneous wound healing and increased fibrovascular invasion of subcutaneous polyvinyl alcohol sponges.
    Puolakkainen PA; Bradshaw AD; Brekken RA; Reed MJ; Kyriakides T; Funk SE; Gooden MD; Vernon RB; Wight TN; Bornstein P; Sage EH
    J Histochem Cytochem; 2005 May; 53(5):571-81. PubMed ID: 15872050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-beta 1 induces the expression of type I collagen and SPARC, and enhances contraction of collagen gels, by fibroblasts from young and aged donors.
    Reed MJ; Vernon RB; Abrass IB; Sage EH
    J Cell Physiol; 1994 Jan; 158(1):169-79. PubMed ID: 8263022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells.
    Francki A; McClure TD; Brekken RA; Motamed K; Murri C; Wang T; Sage EH
    J Cell Biochem; 2004 Apr; 91(5):915-25. PubMed ID: 15034927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis.
    Puolakkainen PA; Brekken RA; Muneer S; Sage EH
    Mol Cancer Res; 2004 Apr; 2(4):215-24. PubMed ID: 15140943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I collagen-deficient Mov-13 mice do not retain SPARC in the extracellular matrix: implications for fibroblast function.
    Iruela-Arispe ML; Vernon RB; Wu H; Jaenisch R; Sage EH
    Dev Dyn; 1996 Oct; 207(2):171-83. PubMed ID: 8906420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered tissue repair in hevin-null mice: inhibition of fibroblast migration by a matricellular SPARC homolog.
    Sullivan MM; Puolakkainen PA; Barker TH; Funk SE; Sage EH
    Wound Repair Regen; 2008; 16(2):310-9. PubMed ID: 18318815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased fibrovascular invasion of subcutaneous polyvinyl alcohol sponges in SPARC-null mice.
    Bradshaw AD; Reed MJ; Carbon JG; Pinney E; Brekken RA; Sage EH
    Wound Repair Regen; 2001; 9(6):522-30. PubMed ID: 11896995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPARC regulates cell cycle progression in mesangial cells via its inhibition of IGF-dependent signaling.
    Francki A; Motamed K; McClure TD; Kaya M; Murri C; Blake DJ; Carbon JG; Sage EH
    J Cell Biochem; 2003 Mar; 88(4):802-11. PubMed ID: 12577314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in vitro model of posterior capsular opacity: SPARC and TGF-beta2 minimize epithelial-to-mesenchymal transition in lens epithelium.
    Gotoh N; Perdue NR; Matsushima H; Sage EH; Yan Q; Clark JI
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4679-87. PubMed ID: 17898292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPARC deficiency results in improved surgical survival in a novel mouse model of glaucoma filtration surgery.
    Seet LF; Su R; Barathi VA; Lee WS; Poh R; Heng YM; Manser E; Vithana EN; Aung T; Weaver M; Sage EH; Wong TT
    PLoS One; 2010 Feb; 5(2):e9415. PubMed ID: 20195533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small interfering RNA inhibition of SPARC attenuates the profibrotic effect of transforming growth factor beta1 in cultured normal human fibroblasts.
    Zhou X; Tan FK; Guo X; Wallis D; Milewicz DM; Xue S; Arnett FC
    Arthritis Rheum; 2005 Jan; 52(1):257-61. PubMed ID: 15641096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of insulin-like growth factor I receptor-dependent expression of p107 and cyclin A in cells that lack the extracellular matrix protein secreted protein acidic and rich in cysteine.
    Basu A; Rodeck U; Prendergast GC; Howe CC
    Cell Growth Differ; 1999 Nov; 10(11):721-8. PubMed ID: 10593648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defects in activation of nitric oxide synthases occur during delayed angiogenesis in aging.
    Bach MH; Sadoun E; Reed MJ
    Mech Ageing Dev; 2005 Apr; 126(4):467-73. PubMed ID: 15722105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed angiogenesis in aging rats and therapeutic effect of adenoviral gene transfer of VEGF.
    Wang H; Keiser JA; Olszewski B; Rosebury W; Robertson A; Kovesdi I; Gordon D
    Int J Mol Med; 2004 Apr; 13(4):581-7. PubMed ID: 15010860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of SPARC in lens epithelial cells results in altered adhesion and extracellular matrix production in vitro.
    Weaver MS; Sage EH; Yan Q
    J Cell Biochem; 2006 Feb; 97(2):423-32. PubMed ID: 16211577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased ADAMTS1 mediates SPARC-dependent collagen deposition in the aging myocardium.
    Toba H; de Castro Brás LE; Baicu CF; Zile MR; Lindsey ML; Bradshaw AD
    Am J Physiol Endocrinol Metab; 2016 Jun; 310(11):E1027-35. PubMed ID: 27143554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of SPARC by VEGF in human vascular endothelial cells.
    Kato Y; Lewalle JM; Baba Y; Tsukuda M; Sakai N; Baba M; Kobayashi K; Koshika S; Nagashima Y; Frankenne F; Noël A; Foidart JM; Hata RI
    Biochem Biophys Res Commun; 2001 Sep; 287(2):422-6. PubMed ID: 11554745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of various growth factors and cytokines on the syntheses of DNA, type I collagen, laminin, fibronectin, osteonectin/secreted protein, acidic and rich in cysteine (SPARC), and alkaline phosphatase by human pulp cells in culture.
    Shiba H; Fujita T; Doi N; Nakamura S; Nakanishi K; Takemoto T; Hino T; Noshiro M; Kawamoto T; Kurihara H; Kato Y
    J Cell Physiol; 1998 Feb; 174(2):194-205. PubMed ID: 9428806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of diabetic nephropathy in SPARC-null mice.
    Taneda S; Pippin JW; Sage EH; Hudkins KL; Takeuchi Y; Couser WG; Alpers CE
    J Am Soc Nephrol; 2003 Apr; 14(4):968-80. PubMed ID: 12660331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.